Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
Open accessThe DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
Male C57BL/6J mice raised on high fat diet (HFD) become prediabetic and develop insulin resistance and sensory neuropathy. The same mice given low doses of streptozotocin are a model of type 2 diabetes (T2D), developing hyperglycemia, severe insulin resistance and diabetic peripheral neuropathy involving sensory and motor neurons. Because of suggestions that increased NAD + metabolism might address glycemic control and be neuroprotective, we treated prediabetic and T2D mice with nicotinamide riboside (NR) added to HFD. NR improved glucose tolerance, reduced weight gain, liver damage and the development of hepatic steatosis in prediabetic mice while protecting against sensory neuropathy. In T2D mice, NR greatly reduced non-fasting and fasting blood glucose, weight gain and hepatic steatosis while protecting against diabetic neuropathy. The neuroprotective effect of NR could not be explained by glycemic control alone. Corneal confocal microscopy was the most sensitive measure of neurodegeneration. This assay allowed detection of the protective effect of NR on small nerve structures in living mice. Quantitative metabolomics established that hepatic NADP + and NADPH levels were significantly degraded in prediabetes and T2D but were largely protected when mice were supplemented with NR. The data justify testing of NR in human models of obesity, T2D and associated neuropathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NMN and NR demonstrated protect against diabetes, Alzheimer disease, endothelial dysfunction, and inflammation.”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In hyperglycaemic mice, nicotinamide riboside administration improved liver steatosis and glucose tolerance, and reduced weight gain257.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [257]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The natural source of oral NR, NAM and NA is largely the NAD+ in the food we eat as broken down by digestion and the microbiome23.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [23]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
Araki, T., Sasaki, Y., & Milbrandt, J. (2004) · Science · doi:10.1126/science.1098014 · Cited by 1,060
Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors
Rutter, J., Reick, M., Wu, L. C., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1060698 · Cited by 1,059
NAD+ metabolism in health and disease
Belenky, P., Bogan, K. L., & Brenner, C. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.11.006 · Cited by 981
Self-citationDiabetic neuropathy: Mechanisms to management
Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.005 · Cited by 790
Bieganowski, P., & Brenner, C. (2004) · Cell · doi:10.1016/s0092-8674(04)00416-7 · Cited by 750
Self-citationBogan, K. L., & Brenner, C. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155443 · Cited by 707
Self-citationSARM1 activation triggers axon degeneration locally via NAD + destruction
Gerdts, J., Brace, E. J., Sasaki, Y., DiAntonio, A., & Milbrandt, J. (2015) · Science · doi:10.1126/science.1258366 · Cited by 593
Surrogate Markers of Small Fiber Damage in Human Diabetic Neuropathy
Quattrini, C., Tavakoli, M., Jeziorska, M., Kallinikos, P., Tesfaye, S., Finnigan, J., Marshall, A., Boulton, A. J. M., Efron, N., & Malik, R. A. (2007) · Diabetes · doi:10.2337/db07-0285 · Cited by 515
Malik, R. A., Kallinikos, P., Abbott, C. A., van Schie, C. H. M., Morgan, P., Efron, N., & Boulton, A. J. M. (2003) · Diabetologia · doi:10.1007/s00125-003-1086-8 · Cited by 505
Belenky, P., Racette, F. G., Bogan, K. L., McClure, J. M., Smith, J. S., & Brenner, C. (2007) · Cell · doi:10.1016/j.cell.2007.03.024 · Cited by 411
Self-citationZiegler, D., Rathmann, W., Dickhaus, T., Meisinger, C., Mielck, A., & for the KORA Study Group (2008) · Diabetes Care · doi:10.2337/dc07-1796 · Cited by 397
Gariani, K., Menzies, K. J., Ryu, D., Wegner, C. J., Wang, X., Ropelle, E. R., Moullan, N., Zhang, H., Perino, A., Lemos, V., et al. (2016) · Hepatology · doi:10.1002/hep.28245 · Cited by 368
Brown, K. D., Maqsood, S., Huang, J.-Y., Pan, Y., Harkcom, W., Li, W., Sauve, A., Verdin, E., & Jaffrey, S. R. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.11.003 · Cited by 277
Sasaki, Y., Araki, T., & Milbrandt, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2320-06.2006 · Cited by 269
(1996) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198523345.001.0001 · Cited by 243
SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice
Yoon, M. J., Yoshida, M., Johnson, S., Takikawa, A., Usui, I., Tobe, K., Nakagawa, T., Yoshino, J., & Imai, S.-I. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.002 · Cited by 243
The phosphate makes a difference: cellular functions of NADP
Agledal, L., Niere, M., & Ziegler, M. (2010) · Redox Report · doi:10.1179/174329210x12650506623122 · Cited by 208
NAD Kinase Levels Control the NADPH Concentration in Human Cells
Pollak, N., Niere, M., & Ziegler, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704442200 · Cited by 196
TARGETED, LCMS-BASED METABOLOMICS FOR QUANTITATIVE MEASUREMENT OF NAD+ METABOLITES
Trammell, S. A., & Brenner, C. (2013) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201301012 · Cited by 192
Self-citationNicotinamide Riboside Is a Major NAD+ Precursor Vitamin in Cow Milk
Trammell, S. A., Yu, L., Redpath, P., Migaud, M. E., & Brenner, C. (2016) · The Journal of Nutrition · doi:10.3945/jn.116.230078 · Cited by 112
Self-citationHuman CD38 is an authentic NAD(P)+ glycohydrolase
BERTHELIER, V., TIXIER, J.-M., MULLER-STEFFNER, H., SCHUBER, F., & DETERRE, P. (1998) · Biochemical Journal · doi:10.1042/bj3301383 · Cited by 109
Evans, C., Bogan, K. L., Song, P., Burant, C. F., Kennedy, R. T., & Brenner, C. (2010) · BMC Chemical Biology · doi:10.1186/1472-6769-10-2 · Cited by 81
Self-citationYorek, M. S., Obrosov, A. A., Shevalye, H., Holmes, A. J., Harper, M. M., Kardon, R. H., & Yorek, M. A. (2015) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12111 · Cited by 65
Self-citationBieganowski, P., Seidle, H. F., Wojcik, M., & Brenner, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513919200 · Cited by 61
Self-citationOccurrence and subcellular distribution of the NAD(P)HX repair system in mammals
Marbaix, A., Tyteca, D., Niehaus, T. D., Hanson, A. D., Linster, C. L., & SCHAFTINGEN, E. V. (2014) · Biochemical Journal · doi:10.1042/bj20131482 · Cited by 55
Davidson, E. P., Coppey, L. J., Holmes, A. J., & Yorek, M. A. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8806 · Cited by 55
Self-citationYorek, M. S., Obrosov, A. A., Shevalye, H., Lupachyk, S., Harper, M. M., Kardon, R. H., & Yorek, M. A. (2014) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12086 · Cited by 51
Self-citationYorek, M. A. (2008) · Current Drug Targets · doi:10.2174/138945008783431736 · Cited by 38
Self-citationNADP+ phosphatase: A novel mitochondrial enzyme
Richter, C. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90718-2 · Cited by 21
Therapy for diabetic neuropathy
Calabek, B., Callaghan, B. C., & Feldman, E. L. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00022-9 · Cited by 15
Brenner, C. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.11.015 · Cited by 8
Self-citation
Cited by
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
Cervenka, I., Agudelo, L. Z., & Ruas, J. L. (2017) · Science · doi:10.1126/science.aaf9794 · Cited by 1,382
“Nevertheless, NAD boosting strategies seem to be successful in restoringmitochondrial and stem cell function (121) and in ameliorating diseases such as muscular dystrophy and diabetes (122, 123) or even prolonging life span (124).”
BackgroundNAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism
Xiao, W., Wang, R.-S., Handy, D. E., & Loscalzo, J. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7216 · Cited by 1,061
“Similar protective effects were also observed in prediabetic and diabetic mice that received NR in their diet (129).”
BackgroundNAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052
“NR protects mice from HFD-induced body weight gain, enhances the liver weight regain by promoting hepatocyte replication and increasing hepatic ATP content in the regenerating liver.(618) NR exhibits beneficial effects in several muscle disorders through improving mitochondrial function and decreasing the UPR in heart…”
BackgroundNAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Yoshino, J., Baur, J. A., & Imai, S.-I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.002 · Cited by 1,061
Metadata
- Authors
- Trammell, S. A. J., Weidemann, B. J., Chadda, A., Yorek, M. S., Holmes, A., Coppey, L. J., Obrosov, A., Kardon, R. H., Yorek, M. A., & Brenner, C.
- Affiliations
- University of Iowa (US)
- Iowa City VA Health Care System (US)
- Corresponding author
- Brenner, Charles
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-05-27
- Volume
- 6
- Issue
- 1
- Pages
- 26933-26933
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4882590
- OpenAlex
- W2400466055
- Cited by
- 301
- References
- 36
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 29 · 2023: 26 · 2022: 55 · 2021: 42 · 2020: 33 · 2019: 34 · 2018: 25 · 2017: 20 · 2016: 4
- FWCI
- 15.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion, other-oa)
- Funders
- U.S. Department of Veterans Affairs (I01 BX001680, BX001680-01, BX001680, RX000889, C9251-C, RX000889-01, I01 RX000889)
- Roy J. Carver Charitable Trust
- Fraternal Order of Eagles
- National Institutes of Health (BX001680)
- National Institute on Alcohol Abuse and Alcoholism (R21AA022371)
- National Institute of General Medical Sciences (T32GM008629)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK081147)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Keywords
- nicotinamide riboside, type 2 diabetes, diabetic neuropathy, NAD+ metabolism, insulin resistance, high-fat diet, streptozotocin-induced diabetes, hepatic steatosis, glucose tolerance, sensory neuropathy, corneal confocal microscopy, NADPH, neuroprotection, obesity
- MeSH terms
- Animals, Blood Glucose, Cornea, Diabetes Mellitus, Experimental, Diabetic Neuropathies, Hypoglycemic Agents, Insulin, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Niacinamide, Obesity, Prediabetic State, Pyridinium Compounds, Streptozocin, Mice, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.